Malignant Peritoneal Neoplasm Completed Phase 2 Trials for Pemetrexed (DB00642)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00230542Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian CancerTreatment
NCT00461786A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal CancerTreatment